Od erektilne disfunkcije do subependimoma mozga: prikaz slučaja by Tatjana Bačun et al.
Acta Clin Croat 2020; 59:173-176 Case Report
doi: 10.20471/acc.2020.59.01.22
Acta Clin Croat, Vol. 59, No. 1, 2020  173
FROM ERECTILE DYSFUNCTION TO BRAIN 
SUBEPENDYMOMA: A CASE REPORT
Tatjana Bačun1,2, Aleksandar Kibel1,3, Dunja Degmečić4,5 and Roman Pavić6,7
1Department of Internal Medicine, Osijek University Hospital Centre, Osijek, Croatia;  
2Department of Internal Medicine, Faculty of Medicine,  
Josip Juraj Strossmayer University of Osijek, Osijek, Croatia;  
3Department of Physiology and Immunology, Faculty of Medicine, University of Osijek, Osijek, Croatia;  
4Department of Psychiatry, Osijek University Hospital Centre, Osijek, Croatia;  
5Department of Psychiatry, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia;  
6University Hospital of Traumatology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia;  
7Department of Surgery, Faculty of Medicine,  
Josip Juraj Strossmayer University of Osijek, Osijek, Croatia
SUMMARY – Endocrinopathies are relatively rare causes of erectile dysfunction. Cases of 
 hyperprolactinemia and pituitary adenomas have been previously reported. We present a clinical case 
of a 27-year-old male with suspected infertility and recent symptoms of erectile dysfunction. Addi-
tional radiological and endocrinologic workup revealed underlying subependymoma, which was ex-
panding in the sellar and suprasellar regions, causing pressure against the pituitary gland. The resulting 
endocrine disorder caused problems that were subjectively at first manifested mainly as erectile dys-
function. The case is an educative example pointing to the need of taking possible intracranial lesions 
in consideration when starting workup in a patient presenting with erectile dysfunction. It may be of 
broad clinical interest not only for endocrinologists but also for practitioners in various fields.
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Introduction
Endocrine disorders are some of the rarer causes of 
erectile dysfunction1-3. The prevalence of low testoster-
one and high prolactin in erectile dysfunction is so rare 
that their routine determination is usually not justi-
fied1. Some recommendations outline that before the 
age of 50, testosterone should be determined only in 
cases of low sexual desire and abnormal physical ex-
amination but that it should be measured in all men 
older than 50 years, whereas prolactin should be deter-
mined only in cases of low sexual desire, gynecomastia 
and/or testosterone less than 4 ng/mL1. Very unusual 
and rare cases have been reported where erectile dys-
function (as the main presenting feature) was caused 
by hyperprolactinemia due to pituitary adenoma2-7. In 
this case report, we present a patient who was initially 
presumed to possibly be infertile, subsequently erectile 
dysfunction was determined and exogenous factors 
were blamed to be the cause. Only when he was re-
ferred to a neurologist because of headaches (and later 
to an endocrinologist), the underlying brain subepen-
dymoma was found. The presented case is a valuable 
example for primary care physicians and clinicians that 
in cases of unclear erectile dysfunction, although rare, 
an endocrinopathy has to be always kept in mind as a 
possible underlying cause and that not only pituitary 
adenomas but also other brain tumors can be involved 
in the etiopathogenesis.
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Case Report
A 27-year-old male, married for 4 years with no 
children, presented with possible infertility and erec-
tile dysfunction, which had previously been interpret-
ed as having been induced by poor social and psycho-
logical situation in the family. During the previous 5 
years, the patient had frequent colds and headaches. 
Sinus x-ray determined ethmoidal and maxillary si-
nusitis; symptoms after antibiotic therapy were paci-
fied. During the previous 4 months, he had symptoms 
of erectile dysfunction. Initial workup revealed mildly 
elevated prolactin levels and reduced levels of testos-
terone. In the last few months, frontal and temporal 
headaches were stronger and the patient was referred 
to a neurologist. Skull x-ray revealed destruction of the 
sella turcica, and computed tomography scan of the 
brain was ordered. The findings showed a well demar-
cated hypodense oval cyst with a diameter of 2.7 cm in 
the sellar and suprasellar area, which was bordered by 
calcifications (Fig. 1, left side). After contrast injection 
there were no signs of imbibition of the described for-
mations; other brain structures were normal. Magnetic 
resonance imaging (MRI) of the pituitary gland 
showed a cystic tumor of 3 cm in diameter, filled with 
dense protein content, which suppressed the pituitary 
gland into the bottom of the sella turcica (Fig. 2, left 
side). The change spread to the interpeduncular cistern 
with compression of brain tissue, destroying the dor-
sum of the sella turcica, and was further expanding 
cranially to the area of the third ventricle, stretching 
the optic chiasm and pressing against the infundibu-
lum. The patient was therefore referred to an endocri-
nologist.
Upon admission, the patient complained of perior-
bital and temporal headaches, erectile dysfunction and 
problems with ejaculation, loss of appetite, and general 
weakness. In childhood, he had varicella and infectious 
jaundice. He smoked for 8 years up to 10 cigarettes per 
day. He took diclofenac sodium (Voltaren) tablets as 
needed. Physical status was normal, with the exception 
of an enlarged left tonsil, and arterial blood pressure of 
105/80 mm Hg. Urgent cortisol and free thyroxine 
(FT4) tests revealed significantly decreased levels 
(cortisol: 11.0 nmol/L; FT4: 7.6 pmol/L), which sug-
gested hypocorticism and hypothyroidism, and substi-
tution therapy was started with hydrocortisone (Cor-
tef ) tablets, 20 mg at 8 am and 10 mg at 4 pm, and 
after 7 days, levothyroxine (Euthyrox) tablets 50 µg, 
thereafter the patient subjectively felt better. The pa-
tient’s follow-up blood pressure was 115-125/80-85 
mm Hg, and laboratory findings were suggestive of 
good substitution. Additional endocrinologic investi-
gations found slightly elevated levels of prolactin, 
 significantly lower values of gonadotropins and testos-
terone (total testosterone: 0.14 nmol/L, free <0.88 
pmol/L), growth hormone, thyroid stimulating hor-
mone (TSH), free triiodothyronine (FT3), FT4, adre-
nocorticotropic hormone (ACTH), and cortisol. Ex-
amination of the visual field indicated bitemporal 
hemianopsia (Fig. 3). Biochemical laboratory tests 
were normal, including proper levels of sodium, potas-
sium and glucose. Electrocardiography and chest x-ray 
were normal, and abdominal ultrasound determined 
gallbladder stones up to 2 cm in size.
Fig. 1. Skull computed tomography scan before (left side) 
and after (right side) neurosurgical procedure. The arrow 
points to the hypodense oval cystic tumor (initially a 
suspected cyst with a measured diameter of about 2.7 cm) 
in the sellar and suprasellar area.
Fig. 2. Brain magnetic resonance image before (left side) 
and after (right side) neurosurgical procedure.  
The arrow points to the cystic tumor (with a measured 
diameter of 3 cm).
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The patient underwent left-sided supraorbital cra-
niotomy and complete surgical removal of the tumor 
at the Department of Neurosurgery. Histopathology 
findings described a subependymoma (grade II). At 
discharge, the following therapy was recommended to 
the patient: desmopressin (Minirin) spray as needed, 
hydrocortisone tablets 20 mg at 8 am and 10 mg at 4 
pm, levothyroxine tablets 75 µg, and analgesics as 
needed. One month after the surgery, follow-up MRI 
was normal. Postoperative findings were normal and 
there were no signs of recurrence. The patient could 
then undergo the planned cholecystectomy. Three 
months after the neurosurgical procedure, endocrino-
logic follow-up review showed cortisol, FT4, sodium, 
potassium, glucose, and blood pressure levels within 
the normal ranges. Prolactin levels were also normal, 
but gonadotropin, testosterone, growth hormone, 
TSH and ACTH were markedly reduced, and serum 
osmolality was normal. The insulin hypoglycemia test 
(ITT) showed an unsatisfactory increase in cortisol 
levels, and the patient continued substitution therapy. 
It was recommended that the hydrocortisone dosage 
be reduced to 15 mg at 8 am and 5 mg at 4 pm, subse-
quently the dosage was further decreased to 10 mg at 
8 am and 5 mg at 4 pm, levothyroxine tablets 75 µg, 
with the addition of testosterone undecanoate (Nebi-
do) 1 g intramuscularly every 12 weeks. After 6 
months, the findings of growth hormone and insulin-
like growth factor 1 (IGF-1) were decreased and the 
ITT showed an unsatisfactory increase in growth 
 hormone. Therefore, replacement therapy with growth 
hormone somatotropin (Norditropin) 0.2 mg daily 
(subcutaneously) was added with monitoring of 
IGF-1 levels. Other findings were suggestive of proper 
substitution. One year after the surgery, the patient 
was in good general condition, but with bitemporal 
hemianopsia, with atrophy of the right optic nerve 
and complete loss of vision on his right eye, panhypo-
pituitarism and impotence. Two years later, with hor-
mone replacement therapy, there was no sexual dys-
function. 
A written informed consent was obtained from the 
patient for publication of this case report and any ac-
companying images.
Conclusion
The presented case illustrates the need to keep not 
only endocrinopathies in mind when a patient pres-
ents with erectile dysfunction, but also that the causes 
may be diverse and that rare brain tumors (other than 
pituitary adenomas) may present themselves mainly 
with erectile dysfunction. In our case, it was a subepen-
dymoma expanding in the sellar and suprasellar area. 
The need for a timely diagnosis is especially evident in 
case of brain tumors, since proper and prompt treat-
ments (surgical and pharmacological, as well as radio-
Fig. 3. Visual field test (Goldmann perimetry) indicating bitemporal hemianopsia.
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therapy) can have very successful outcomes8. Previ-
ously, hypogonadism and resulting erectile dysfunction 
have been described as a result of suspected craniopha-
ryngioma9. There is an interesting recent case report of 
a young male with back pain and erectile dysfunction, 
where spinal myxopapillary ependymoma was deter-
mined to be the cause10, but we are not aware of any 
previous case reports of brain subependymomas or ep-
endymomas as the main causes of erectile dysfunction 
through endocrine disorders (hypogonadism). In that 
respect, this important case is extremely interesting 
and may hopefully be of assistance to clinicians in 
their everyday work with patients who present with 
erectile dysfunction as the main problem.
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Sažetak
OD EREKTILNE DISFUNKCIJE DO SUBEPENDIMOMA MOZGA: PRIKAZ SLUČAJA
T. Bačun, A. Kibel, D. Degmečić i R. Pavić
Endokrinopatije su relativno rijetki uzroci erektilne disfunkcije. Prethodno su opisani slučajevi hiperprolaktinemije i 
adenoma hipofize. Mi prikazujemo klinički slučaj 27-godišnjeg muškarca sa sumnjom na neplodnost i nedavnim simptomi-
ma erektilne disfunkcije. Dodatna radiološka i endokrinološka obrada otkrila je u podlozi subependimom s ekspanzijom u 
selarnoj i supraselarnoj regiji, s kompresijom na hipofizu. Posljedični endokrini poremećaj uzrokovao je probleme koji su se 
prvobitno subjektivno manifestirali pretežno kao erektilna disfunkcija. Slučaj je edukativni primjer koji upućuje na to da je 
kod bolesnika koji se prezentira s erektilnom disfunkcijom pri započinjanju obrade potrebno uzeti u obzir moguće intra-
kranijske lezije. Slučaj bi mogao biti klinički zanimljiv ne samo za endokrinologe, nego i za praktičare iz drugih stručnih 
područja.
Ključne riječi: Erektilna disfunkcija; Endokrini sustav, bolesti; Prolaktin; Testosteron; Mozak, tumori; Gliom, subependimalni
